Jeremy Snider

1.0k total citations
40 papers, 665 citations indexed

About

Jeremy Snider is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jeremy Snider has authored 40 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Jeremy Snider's work include Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Behavioral Health and Interventions (7 papers). Jeremy Snider is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Behavioral Health and Interventions (7 papers). Jeremy Snider collaborates with scholars based in United States, Canada and Australia. Jeremy Snider's co-authors include W. Douglas Evans, Jasmine Wallace, Jonathan L. Blitstein, Lorien C. Abroms, Daniel R. Szekely, Peter E. Nielsen, Emily Castellanos, Virginia Fisher, Ha Thi Hong Nguyen and Oyunbileg Magvanjav and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Jeremy Snider

37 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeremy Snider United States	12	296	164	109	96	89	40	665
Kuang‐Yi Wen United States	16	419 1.4×	172 1.0×	104 1.0×	81 0.8×	60 0.7×	55	968
Ole Nørgaard Denmark	16	493 1.7×	113 0.7×	94 0.9×	30 0.3×	72 0.8×	48	1.1k
H. Shelton Brown United States	16	368 1.2×	290 1.8×	162 1.5×	41 0.4×	36 0.4×	58	1.1k
Mírian Carvalho de Souza Brazil	15	244 0.8×	162 1.0×	45 0.4×	31 0.3×	59 0.7×	51	728
Tabetha A. Brockman United States	17	275 0.9×	169 1.0×	43 0.4×	92 1.0×	29 0.3×	62	829
Meghan C. Halley United States	16	328 1.1×	285 1.7×	49 0.4×	66 0.7×	34 0.4×	54	928
Jeffrey J. Guidry United States	13	277 0.9×	153 0.9×	72 0.7×	57 0.6×	45 0.5×	31	759
Yan Kwan Lau United States	14	211 0.7×	99 0.6×	68 0.6×	68 0.7×	149 1.7×	30	624
Camille A. Clare United States	15	163 0.6×	343 2.1×	242 2.2×	96 1.0×	27 0.3×	46	1.0k
Dinorah Martinez Tyson United States	18	245 0.8×	164 1.0×	152 1.4×	85 0.9×	101 1.1×	57	1.2k

Countries citing papers authored by Jeremy Snider

Since Specialization

Citations

This map shows the geographic impact of Jeremy Snider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy Snider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy Snider more than expected).

Fields of papers citing papers by Jeremy Snider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy Snider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy Snider. The network helps show where Jeremy Snider may publish in the future.

Co-authorship network of co-authors of Jeremy Snider

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy Snider. A scholar is included among the top collaborators of Jeremy Snider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy Snider. Jeremy Snider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Perales, Miguel‐Angel, Joseph P. McGuirk, Mark R. Fesen, et al.. (2025). Real-World Treatment Patterns of Large B-Cell Lymphoma Patients over Time in a Post-CAR T Approval Era. Transplantation and Cellular Therapy. 31(2). S391–S391.

Bartley, Karen, et al.. (2025). The prognostic impact of human epidermal growth factor receptor 2 status in metastatic colorectal cancer. Future Science OA. 11(1). 2527482–2527482. 1 indexed citations

McGuirk, Joseph P., Mark R. Fesen, Scott D. Ramsey, et al.. (2024). Treatment Patterns and Predictors of Survival after First Line Therapy in Large B-Cell Lymphoma in a Real-World US Cohort. Blood. 144(Supplement 1). 2367–2367.

Guadamuz, Jenny S., Xiaoliang Wang, Rebecca A. Miksad, et al.. (2023). Socioeconomic status and inequities in treatment initiation and survival among patients with cancer, 2011-2022. JNCI Cancer Spectrum. 7(5). 27 indexed citations

Gandara, David R., Neeraj Agarwal, Shilpa Gupta, et al.. (2023). Tumor mutational burden (TMB) measurement from an FDA-approved assay and real-world overall survival (rwOS) on single-agent immune checkpoint inhibitors (ICI) in over 8,000 patients across 24 cancer types.. Journal of Clinical Oncology. 41(16_suppl). 2503–2503. 10 indexed citations

Schrock, Alexa B., Jessica Lee, Jaideep Sandhu, et al.. (2021). RAS Amplification as a Negative Predictor of Benefit from Anti-EGFR–Containing Therapy Regimens in Metastatic Colorectal Cancer. The Oncologist. 26(6). 469–475. 7 indexed citations

Swaminathan, Akshay, et al.. (2021). PCN198 Statistical Methods for Pantumor Analysis: Models to Account for Tumor-Level Heterogeneity. Value in Health. 24. S56–S56. 1 indexed citations

Bazhenova, Lyudmila, Jeremy Snider, Emily Castellanos, et al.. (2021). TRK Fusion Cancer: Patient Characteristics and Survival Analysis in the Real-World Setting. Targeted Oncology. 16(3). 389–399. 34 indexed citations

Antonarakis, Emmanuel S., Russell W. Madison, Jeremy Snider, et al.. (2020). Association of BRCA alteration (alt) type with real-world (RW) outcomes to PARP inhibitors (PARPi) in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 38(15_suppl). 5527–5527. 2 indexed citations

10.

Yezefski, Todd, Yi Chen, Caroline Speers, et al.. (2020). Comparison of Treatment, Cost, and Survival in Patients With Metastatic Colorectal Cancer in Western Washington, United States, and British Columbia, Canada. JCO Oncology Practice. 16(5). e425–e432. 5 indexed citations

11.

Castellanos, Emily, Jeremy Snider, Siraj M. Ali, et al.. (2019). Tumor mutational burden (TMB) and PD-L1 expression as predictors of response to immunotherapy (IO) in NSCLC.. Journal of Clinical Oncology. 37(15_suppl). 2630–2630. 6 indexed citations

12.

Evans, W. Douglas, et al.. (2019). The Saleema initiative in Sudan to abandon female genital mutilation: Outcomes and dose response effects. PLoS ONE. 14(3). e0213380–e0213380. 24 indexed citations

13.

Evans, W. Douglas, Jessica M. Rath, Elizabeth C. Hair, et al.. (2017). Effects of the truth FinishIt brand on tobacco outcomes. Preventive Medicine Reports. 9. 6–11. 14 indexed citations

14.

Snider, Jeremy, Betty Bekemeier, Douglas A. Conrad, & David Grembowski. (2017). Federally Qualified Health Center Substitution of Local Health Department Services. American Journal of Preventive Medicine. 53(4). 405–411. 6 indexed citations

15.

Evans, W. Douglas, Jasmine Wallace, & Jeremy Snider. (2015). The 5-4-3-2-1 Go! Brand to Promote Nutrition and Physical Activity: A Case of Positive Behavior Change but Negative Change in Beliefs. Journal of Health Communication. 20(5). 512–520. 6 indexed citations

16.

Evans, W. Douglas, et al.. (2015). Adherence to clinical preventive services guidelines: Population-based online randomized trial. SSM - Population Health. 1. 48–55. 8 indexed citations

17.

Evans, W. Douglas, et al.. (2014). Initial Outcomes From a 4-Week Follow-Up Study of the Text4baby Program in the Military Women’s Population: Randomized Controlled Trial. Journal of Medical Internet Research. 16(5). e131–e131. 67 indexed citations

18.

Evans, W. Douglas, et al.. (2014). Effects of the Above the Influence Brand on Adolescent Drug Use Prevention Normative Beliefs. Journal of Health Communication. 19(6). 721–737. 11 indexed citations

19.

Evans, W. Douglas, Jasmine Wallace, & Jeremy Snider. (2012). Pilot evaluation of the text4baby mobile health program. BMC Public Health. 12(1). 1031–1031. 157 indexed citations

20.

Nguyen, Ha Thi Hong, Jeremy Snider, Nirmala Ravishankar, & Oyunbileg Magvanjav. (2011). Assessing public and private sector contributions in reproductive health financing and utilization for six sub-Saharan African countries. Reproductive Health Matters. 19(37). 62–74. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact